Compounding pharmacies report adverse events to FDA
Images were captured using confocal and inverted fluorescence microscopes
Toxicology and applied pharmacology, 23(1), 5461.
GSH stock buffer (consisting of EDTA (ehylenediaminetetraacetic acid, Sigma-Aldrich, Zwijndrecht, Netherlands), monosodium phosphate (Sigma-Aldrich, Zwijndrecht, Netherlands) and MilliQ) was added to supernatant to receive measurement sample
Most compounds specifically targeting cancer NADPH metabolism are in preclinical studies, thus there are still challenges to address before these compounds enter the clinic
In REDEFINE 1 (overweight/obesity without T2D), CagriSema achieved mean weight reductions of 20.4-22.7% (vs 2.3-3.0% placebo) at 68 weeks, with 53.6% and 34.7% of patients achieving 20% and 25% weight loss, respectively